Treatment for Alzheimer Disease

Phase-Based Progress Estimates
Voyage Medical, Tempe, AZ
Alzheimer Disease+2 More
All Sexes
What conditions do you have?

Study Summary

The study utilizes investigational software, the SPARK Test, with an FDA-cleared electroencephalography (EEG) amplifier and EEG cap to collect and then analyze patient EEG data.

Eligible Conditions

  • Alzheimer Disease
  • Cognitive Impairment (CI)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: 10 weeks

10 weeks
Alzheimer's Disease positive vs. negative indication for biomarker-confirmed AD
Assessment of patients SPARK Test data
Mean absolute error for specific cognitive assessment
Software malfunction occurrences

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

800 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 10 weeks
Closest Location: Voyage Medical · Tempe, AZ
N/AFirst Recorded Clinical Trial
1 TrialsResearching Alzheimer Disease
0 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are legally authorized to consent to the procedure.
You spend >8 hours per week with primary subject.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.